Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;35(5):541-6.
doi: 10.3275/8411. Epub 2012 May 8.

Rising incidence and challenges of childhood diabetes. A mini review

Affiliations
Review

Rising incidence and challenges of childhood diabetes. A mini review

G Cizza et al. J Endocrinol Invest. 2012 May.

Abstract

Approximately 215,000 people younger than 20 yr of age, or 1 in 500 children and adolescents, had diabetes in the United States in 2010--and the incidence is rising. We still have insufficient knowledge about the precise mechanisms leading to the autoimmune mediated β-cell destruction in Type 1 diabetes, and the β-cell failure associated with insulin resistance in Type 2 diabetes. Long-term complications are similar: micro- and macrovascular disease occurs prematurely and presents an enormous burden on affected individuals, often as early as in middle age. In Type 1 diabetes, technological advances have clearly improved blood glucose management, but chronic peripheral over-insulinization remains a problem even with the most advanced systems. Thus, in Type 1 diabetes our research must focus on 1) finding the stimulus that ignites the immune response and 2) developing treatments that avoid hyperinsulinemia. In Type 2 diabetes in youth, the challenges start much earlier: most young patients do not even benefit from existing therapies due to non-compliance. Therefore, prevention of Type 2 diabetes and improvement of compliance, especially with non-pharmacological interventions, are the greatest challenges.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Rate of new cases of Type 1 and Type 2 diabetes among children, adolescents, and young adults <20 yr of age, by race/ethnicity, between 2002 and 2005. NHW: non-Hispanic whites; NHB: non-Hispanic blacks; H: Hispanics/Latinos; API: Asian/Pacific Islander Americans; Al: American Indians. Source: SEARCH for Diabetes in Youth Study (diabetes.niddk.nih.gov/dm/pubs/statistics/images/DMStats2011-Chart3.jpg&imgrefurl=http).
Fig. 2
Fig. 2
Genetic predisposition and a combination of obesity and β-cell failure lead to Type 2 diabetes. Several epigenetic and environmental factors contribute to both, weight gain and loss of β-cell function. Purple arrows indicate the contribution to obesity, green arrows to β-cell failure. The appropriate references can be found in the text.

References

    1. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700. - PubMed
    1. Klingensmith GJ, Pyle L, Arslanian S, et al. TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33:1970–5. - PMC - PubMed
    1. Liu EH, Digon BJ, 3rd, Hirshberg B, et al. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia. 2009;52:1369–80. - PMC - PubMed
    1. Rother KI, Spain LM, Wesley RA, et al. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care. 2009;32:2251–7. - PMC - PubMed
    1. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008;371:1777–82. - PubMed

Publication types